Sergio Rosenzweig, MD, PhD
CIS President
Moderators: Troy Torgerson, MD, PhD & Hana Niebur, MD
2:30pm - 2:45pm The contribution of mosaic variants to molecular diagnosis in subjects with immune disorders - Magdalena A. Walkiewicz, PhD
2:45pm - 3:00pm The effects of Microbiome and Immunoglobulin Therapy on Immune Dysregulation in Common Variable Immunodeficiency - Joud Hajjar, MD, MS
3:00pm - 3:15pm Who's your data? Primary immune deficiency differential diagnosis prediction via machine learning and data mining of the USIDNET registry - Saul O. Lugo Reyes, MD, MS
3:15pm - 3:30pm Reduced mTORC1 signal in patients with dominant negative STAT3 mutations - Jacob Y. Edinger, BS
3:30pm - 3:45pm PLCG2 variants observed in human immune dysregulation alter B cell activity - Michael Ombrello, MD
Moderators: Luigi Notarangelo, MD & Ben Prince, MD
4:05pm - 4:35pm Development of SARS-CoV-2 neutralizing nanobodies - Jianliang Xu, PhD
4:35pm - 5:05pm COVID-19 Vaccine Responses in IEIs - Luigi Notarangelo, MD
5:05pm - 5:35pm Genetic susceptibility to MIS-C - Shen-Ying Zhang, MD, PhD
5:35pm - 5:45pm ABSTRACT
Proteomic profiling reveals restricted heavy chain subfamily expression of vaccine-elicited SARS-CoV-2 spike-specific antibodies in patients with primary antibody deficiencies - Alexander Troelnikov, MBBS, BMedSci (Hons)
Moderator: Tom Fleisher, MD & Nikita Raje, MD, MSc
Hepatitis C: The End of the Beginning and Possibly The Beginning of the End
Harvey Alter, MD
*Separate ticket purchase required*
Friday, April 1 |
Back to top |
*Separate Registration Required*
Moderators: Claire Booth, MBBS, MRCPCH, MSc and Sung-Yun Pai, MD
8:00am - 8:30am New Approaches to Gene Correction for Inborn Errors of Immunity - Claire Booth, MBBS, MRCPCH, MSc
8:30am - 9:00am Gene Therapy for IPEX Syndrome: Present and Future - Rosa Bacchetta, MD
9:00am - 9:30am Advanced Genetic Engineering of Hematopoiesis for the Treatment of Immune Deficiencies - Pietro Genovese, PhD
9:30am - 9:45am ABSTRACT
Epigenetic quantification of the Treg specific FOXP3 regulatory region (TSDR) can assist with variant classification and denote disease severity in IPEX syndrome - Rebecca C. Wyatt, PhD
Moderators: Scott Canna, MD & Talal Mousallem, MD
10:15am - 10:45am Novel insights to genetics and immunopathology of HLH/MAS - Yenan Bryceson, PhD
10:45am - 11:15am Update on Novel Therapies for HLH/MAS: A Focus on Cytokine Inhibition - Kim Nichols, MD
11:15am - 11:30am Multi-disciplinary management of HLH/MAS - Lauren Henderson, MD
11:30am - 11:45am ABSTRACT
Phase 3 Placebo-Controlled, Randomized Clinical Trial Outcomes of PI3K Delta Inhibitor Leniolisib in Patients with Activated PI3K Delta Syndrome (APDS/PASLI) - V. Koneti Rao, MD, FRCPA
11:45am - 12:45pm Lunch Symposium
ADA-SCID: Disease Management & Treatment Landscape Symposium
Sponsored by:
To RSVP for the event, click here
12:30pm - 1:00pm Lightning Poster Presentations
1:00pm - 2:00pm Friday Poster Session
Moderators: Elie Haddad, MD, PhD & Troy Torgerson, MD, PhD
Panelists: Zuhair Ballas, Vincent Bonagura, Jean Laurent-Casanova
Moderators: Jenna Bergerson, MD & Cecila Poli, MD, PhD
3:00pm - 3:20pm Changing Landscape of IEI in India: A decade of progress - Sudhir Gupta, MD, PhD, MACP
3:20pm - 3:40pm Implementation of Newborn Screening for IEI in Brazil - Antonio Condino-Neto, MD, PhD
3:40pm - 4:00pm Looking for PIDs within African endemic diseases - Nahla Erwa, MBBS
4:00pm - 4:20pm PID management in Israel and the Palestinian Authority territories: Doing our best in a conflictive scenario - Raz Somech, MD, PhD
Moderators: Roshini Abraham, PhD & Melissa Gans, MD
Speaker: Michael Hershfield, MD
Organized by the Diversity & Inclusion and Women in Clinical Immunology Sciences Committees
"Professional Work in a 'Post-Racial' Era: Black Health Care Workers in the New Economy"
Adia Harvey Wingfield
Mary Tileston Hemenway Professor of Arts & Sciences,
​Associate Dean for Faculty Development, and Professor of Sociology
Hiding on the X: Rethinking Perceptions of Carriers of X-Linked CGD
Click here to register for the dinner symposium
Sponsored by:
Saturday, April 2 |
Back to top |
Patient Case-Based Panel Discussion: The Pursuit of Reliable Infection Protection in PIDD
Sponsored by:
*Separate Registration Required*
Moderator: Sarah Nicholas, MD and Lisa Forbes-Satter, MD
8:00am - 8:30am CAR-T Hyperinflammation and HLH - Dave Teachey, MD
8:30am - 9:00am Checkpoint Inhibitors - Terri Laufer, MD
9:00am - 9:30am Solid Organ Transplant Rejection and Immunodeficiency: a fine balance - Sarah Nicholas, MD
9:30am - 9:45am ABSTRACT
Perturbation of adaptive immune responses to SARS-CoV-2 infection - Ottavia M. Delmonte, MD, PhD
Moderators: Emily Mace, PhD & Rebecca Marsh, MD
9:45am - 10:00am CLIA, CAP and other acronyms: Regulatory oversight in the clinical diagnostic laboratory - Tom Fleisher, MD
10:00am-10:15am - Ushering in the genomic era in the clinical laboratory- Ivan Chinn, MD
10:15am-10:30am - What you wanted to know but didn’t about development, validation and implementation of clinical immunology tests - Sam Chiang, PhD
10:30am - 10:45am - Functional flow cytometry in the clinical lab: Shapeshifting to meet the regulatory challenges and clinical needs - Roshini Abraham, PhD
10:45am - 11:15am - Round Table Discussion
Moderator: Elie Haddad, MD, PhD & Carolyn Baloh, MD
The Host, the Pathogen and the Strategies
Kate Sullivan, MD, PhD
*CIS Members Only*
12:30pm - 1:30pm ECI Lunch/Career Development Panel
Troy Torgerson, MD, PhD - Representing a career in industry
Mike Keller, MD - Representing a career in research
Jennifer Heimall, MD - Representing program leadership/Fellowship Program Director
12:45pm - 1:45pm Lunch Symposium
Challenges Associated With Respiratory Viral Infections in Patients with Primary Immunodeficiency: An Expert Discussion
Sponsored by:
1:00pm - 1:30pm Saturday Lightning Poster Presentations
1:30pm - 2:30pm Poster Session II: Saturday Presenters
Moderators: Lisa Forbes-Satter, MD and Jenny Shin, MD, PhD
History of CVID as a non-genetic clinical syndrome evolving to single gene diseases
Charlotte Cunningham-Rundles, MD, PhD
*Complimentary with Annual Meeting Registration*
Management of Congenital Athymia: A Case-Based Approach
Sponsored by:
To RSVP for the event and view more information click here
Sunday, April 3 |
Back to top |
Moderators: Steve Holland, MD and Niraj Patel, MS, MD
7:00am - 7:30am - Modeling genetics of human disease susceptibility - Nadia Rosenthal
7:30am - 8:00am - Coccidioidomycosis- Steve Holland, MD
Moderators: Steve Holland, MD & Harry "Adrian" Lesmana
9:00am - 9:30am - cREL - Anne Puel
9:30am - 9:45am - A surface homophilic receptor LY9 governs IFN-γ and IL-17/22 immunity to protect humans from tuberculosis and candidiasis - Masato Ogishi
9:45am - 10:00am - Gene Expression Profiling and Signaling Pathway Analysis of Tolerance in an IL-7R- SCID Patient Following Bilateral Orthotopic Lung Transplant and Bone Marrow Transplant from the Same Cadaveric Donor - Paul Szabolcs
Moderators: Steve Holland, MD & Harry "Adrian" Lesmana
9:20am - 9:35am - Identification of Germline Monoallelic Mutations in IKZF2 in Patients with Immune Dysregulation - Daniel Mayr
9:35am - 9:50am - ARPC5 deficiency, a novel actinopathy presenting with Job’s syndrome /STAT3 GOF-like features and dissecting IL-6 classical and trans-signaling - Cristiane Nunes dos Santos
9:50am - 10:05am - Human germline biallelic complete NFAT1 deficiency causes the triad of progressive joint contractures, osteochondromas, and susceptibility to B cell malignancy - Stuart Turvey
10:05am - 10:20am - TCF3 haploinsufficiency disease: a question of gene dosage and penetrance - Brigette Boast
10:20am - 10:35am - Breaking of Immune Tolerance in Down Syndrome: A Triad of Cytokines, Activated T cells and Extrafollicular B Cells - Louise Malle
10:35am - 10:50am - Germline Gain-Of-Function Variants in JAK1 Lead to a Spectrum of Autoinflammation - Michael Espino
10:50am - 11:05am - COVID-19 Vaccine Usage, Effectiveness, and Safety in Patients with Inborn Errors of Immunity: A USIDNET Registry Study - John McDonnell